These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9805679)

  • 1. [Long-term administration study of propiverine hydrochloride (BUP-4 tablets) in pollakiuria and urinary incontinence].
    Noguchi K; Masuda M; Noguchi S; Kubota Y; Hosaka M; Senga Y; Sano K; Miyai K; Kanno H; Kitami K; Fujinami K; Miura T; Kondo I; Kawasaki C; Moriyama M; Hara Y; Ida T; Fukuoka H; Nakagawa J; Kitajima N; Fukuda M; Satomi Y; Takahashi T; Yamaguchi T; Shiozaki H
    Hinyokika Kiyo; 1998 Sep; 44(9):687-93. PubMed ID: 9805679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
    Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
    Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Propiverine hydrochloride improved correlatively subjective QOL and objective findings in Japanese patients with urinary frequency and/or incontinence].
    Noguchi K; Yamagishi T; Suzuki K; Kondo K; Kishida T; Saito K; Sekiguchi Y; Nakaigawa N; Ogawa T; Uemura H; Yao M; Kubota Y; Kawai M; Okajima K; Kobayashi K; Moriyama M; Kinoshita Y; Mikata K; Kitami K; Masuda M; Saito R; Murai T; Tomoda T; Noguchi S; Sakai N; Hamano A; Nomura S; Sato K
    Hinyokika Kiyo; 2006 May; 52(5):343-8. PubMed ID: 16758722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experience in the use of propiverine hydrochloride (P-4) for patients suffering from urinary frequency and/or incontinence].
    Yokoyama O; Miyazaki K; Ishida T; Fujita Y; Hisazumi H
    Hinyokika Kiyo; 1990 Apr; 36(4):517-23. PubMed ID: 2378310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and safety of propiverine on improvement of symptoms and QOL for female patients with wet overactive bladder].
    Kato M; Matsukawa Y; Kato K; Kondo A; Yamada S; Hattori R; Gotoh M
    Hinyokika Kiyo; 2008 Mar; 54(3):165-71. PubMed ID: 18411770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical effect of terodiline hydrochloride on pollakisuria and urinary incontinence].
    Sugiyama T; Kiwamoto H; Uchida A; Nagai N; Park YC; Kurita T; Ikegami M; Nakanishi A; Kawamura M; Umekawa T
    Hinyokika Kiyo; 1990 Nov; 36(11):1371-7. PubMed ID: 2288317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Abrams P; Cardozo L; Chapple C; Serdarevic D; Hargreaves K; Khullar V;
    Int J Urol; 2006 Jun; 13(6):692-8. PubMed ID: 16834644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and urodynamic effects of oral propiverine therapy in neurogenic urinary incontinence. A multicenter study for optimizing dosage].
    Mazur D; Göcking K; Wehnert J; Schubert G; Herfurth G; Alken RG
    Urologe A; 1994 Sep; 33(5):447-52. PubMed ID: 7974935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of terodiline hydrochloride for the treatment of urinary frequency and urinary incontinence, and its cardiovascular adverse effects].
    Yoshihara H; Yasumoto R; Kishimoto T; Maekawa M; Horii A; Nishijima T; Sugimoto T; Kashiwara N; Tsujita M; Senjyu M
    Hinyokika Kiyo; 1992 Aug; 38(8):967-72. PubMed ID: 1414748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effect of propiverine hydrochloride on urinary incontinence].
    Watanabe H; Uchida M; Kojima M
    Hinyokika Kiyo; 1998 Mar; 44(3):199-206. PubMed ID: 9589886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of long-term administration of terodiline hydrochloride for the treatment of patients with pollakisuria and incontinence].
    Tsujimoto Y; Fujisue H; Shima H; Ikoma F; Sakurai T; Sato Y; Tokizane M; Akiyama K; Kato S; Nakachi K
    Hinyokika Kiyo; 1988 Apr; 34(4):724-32. PubMed ID: 3400552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy].
    Kamimura N; Hatakeyama S; Kudo S; Yoneyama T; Hashimoto Y; Koie T; Yoshikawa K; Kawaguchi T; Takahashi S; Ohyama C
    Hinyokika Kiyo; 2011 Feb; 57(2):71-6. PubMed ID: 21412038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and urodynamic effects of propiverine in patients suffering from urgency and urge incontinence. A multicentre dose-optimizing study.
    Mazur D; Wehnert J; Dorschner W; Schubert G; Herfurth G; Alken RG
    Scand J Urol Nephrol; 1995 Sep; 29(3):289-94. PubMed ID: 8578271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parkinsonism induced by propiverine hydrochloride--report of 3 cases].
    Sugiyama Y
    Rinsho Shinkeigaku; 1997 Oct; 37(10):873-5. PubMed ID: 9490895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical effect of terodiline hydrochloride on nervous pollakisuria or irritative bladder].
    Yoneyama T; Ogawa A; Fukui J; Wajiki M; Tomita Y; Igawa Y; Yanagisawa A; Uchiyama S; Watanabe K; Aida Y
    Hinyokika Kiyo; 1987 Feb; 33(2):319-26. PubMed ID: 3591595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effect of propiverine in patients with urge or stress incontinence. Kobe University Incontinence Study Group.
    Okada H; Sengoku J; Gohji K; Arakawa S; Kamidono S
    Hinyokika Kiyo; 1998 Jan; 44(1):65-9. PubMed ID: 9503214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
    Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
    Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies of terodiline hydrochloride and clenbuterol hydrochloride for urinary frequency and incontinence].
    Katsumi T; Murayama K; Tajika E; Nakamura T; Kawaguchi K
    Hinyokika Kiyo; 1991 Nov; 37(11):1575-80. PubMed ID: 1767784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tolerance and effectiveness of propiverine hydrochloride in 752 patients with symptoms of detrusor hyperactivity and increased sensitivity and irritability of the urinary bladder: results of a study monitoring drug utilization].
    Halaska M; Martan A; Voigt R; Kaplan F; Raus K; Masata J; Klemenc J
    Ceska Gynekol; 1997 Oct; 62(5):259-64. PubMed ID: 9600163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effect of oxybutynin hydrochloride (1 mg/tablet)].
    Yokoyama E; Fujino A; Kubo S; Mashimo S; Koshiba K
    Hinyokika Kiyo; 1990 Jul; 36(7):869-76. PubMed ID: 2239587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.